A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants

Inclusion Criteria: * Participants must be Chinese (both biological parents are ethnically Chinese). * Body mass index (BMI) of 18.0 through 28.0 kilograms/meter squared (kg/m\^2), inclusive. BMI = weight (kg)/\[height (m)\]\^2. * Body weight ≥ 50.0 kg. Exclusion Criteria: * History of clinically significant infection within 4 weeks of dosing on Day 1. * Significant medical history/condition, laboratory abnormality, or psychiatric illness that would prevent the participant from participating in the study. * Condition(s) which may confound the ability to interpret data from the study, as determined by the investigator. Other protocol-defined inclusion/exclusion criteria apply.